ABVC BIOPHARMA, INC. — Form 8-K/A
Filed August 12, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 15/100
What the filing says
ABVC Biopharma (market cap ~$37M) filed an amended Form 8-K/A on 2026-08-12, amending its report from 2026-08-03. The filing metadata does not disclose the substantive amendment details, counterparties, dollar amounts, percentages, share counts, or what specifically changed. Only Item 8.01 (Other Events) is referenced, but the actual content is not provided in the accessible text.
Why this rating
Cannot assess materiality without substantive disclosure. Amendment alone is routine; specifics determine impact.
Extracted items
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.